Assitance Publique Hopitaux de Marseille
Marseille, 13, France
NCT Number: NCT02816307
Infective endocarditis remains a serious disease that requires fast and specialized support in 2012. However, 24% of endocarditis unanswered etiology. The systematic use of new policy diagnosis, including (i) a systematic use of specific PCR techniques and (ii) the search for markers of inflammatory and tumoral diseases, should increase the number of positive etiological diagnosis of culture-negative samples.
Secondly, because of the seriousness of the disease, the investigators were led to develop a new score: score for admission. This score, realized in less than 4 hours from the admission of the suspected patient with endocarditis, should allow for immediate probabilistic antibiotic treatment after completion of the diagnostic kit. The modified Duke score give its results in 4 to 7 days. With the score of admission thus diagnostic processes are accelerated and, where appropriate, empirical antibiotic therapy started.
Primary: Evaluate the effectiveness of the new diagnostic strategy on etiological identification of endocarditis.
Secondary: Validate the "admission" score compared to the modified Duke score.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Marseille, 13, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 years
Time frame: 1 day
Time frame: 1day
Assistance Publique Hopitaux De Marseille
Other
Acronym: ENDOC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07529730
Cardiovascular Diseases, Endocarditis
Alessandria, AL, Italy
View Trial DetailsNCT07523646
Anemia, Cardiovascular Diseases
Copenhagen, Denmark
View Trial DetailsNCT07511673
Cardiovascular Diseases, Endocarditis
Gothenburg, Sweden
View Trial DetailsNCT07282002
Cardiovascular Diseases, Endocarditis
View Trial Details